From February 2022:
Two people with leukemia achieved remission over a decade after being infused with CAR-T cells, immune cells that had been modified in a lab, according to a new study. The findings suggest that this approach could be a long-term therapy for leukemia — and some researchers describe it as a possible cure.
Chimeric antigen receptor or CAR-T cell therapy may be a “curative regimen” for chronic lymphocytic leukemia, according to the researchers, who announced their findings in a news briefing this week. Chronic lymphocytic leukemia accounts for about a quarter of new cases of leukemia.
https://www.cnn.com/2022/02/02/health/cancer-t-cell-therapy-remission-study/index.html
and discussion at https://news.ycombinator.com/item?id=30192209.
